Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis
- PMID: 6673488
- DOI: 10.1111/j.1651-2227.1983.tb09831.x
Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis
Abstract
Amyloid-related serum protein (SAA) was analysed by radioimmunoassay in 32 patients with cystic fibrosis, and compared with other acute phase reactants and lung function. The level of SAA showed significant correlation with impaired lung function due to active Pseudomonas aeruginosa infection, and also to C-reactive protein. SAA seemed to correlate better to the presence of bacteria in sputum than C-reactive protein. Ten of the patients received extensive antibiotic treatment for their pulmonary infection, and falling serum levels of SAA paralleled the clinical response to treatment. Thus the concentration of SAA in these patients was a valuable guide for the selection of patients for antibiotic treatment as well as a good parameter of the response to therapy.
Similar articles
-
Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients.J Clin Lab Anal. 1992;6(4):219-24. doi: 10.1002/jcla.1860060410. J Clin Lab Anal. 1992. PMID: 1403341
-
Modification of some markers of inflammation during treatment for acute respiratory exacerbation in cystic fibrosis.Acta Paediatr. 1992 Mar;81(3):227-30. doi: 10.1111/j.1651-2227.1992.tb12209.x. Acta Paediatr. 1992. PMID: 1511195
-
Comparison of 6 and 8 hourly tobramycin dosing intervals in treatment of pulmonary exacerbations in cystic fibrosis patients.Pediatr Infect Dis J. 1991 May;10(5):381-6. doi: 10.1097/00006454-199105000-00007. Pediatr Infect Dis J. 1991. PMID: 1906161 Clinical Trial.
-
Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.Drugs. 2003;63(22):2501-20. doi: 10.2165/00003495-200363220-00015. Drugs. 2003. PMID: 14609360 Review.
-
[Clinical importance of determination of serum amyloid A].Srp Arh Celok Lek. 2004 Jul-Aug;132(7-8):267-71. doi: 10.2298/sarh0408267j. Srp Arh Celok Lek. 2004. PMID: 15615187 Review. Serbian.
Cited by
-
Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza.J Clin Pathol. 1985 Mar;38(3):312-6. doi: 10.1136/jcp.38.3.312. J Clin Pathol. 1985. PMID: 3973057 Free PMC article.
-
Oh my gut! Is the microbial origin of neurodegenerative diseases real?Infect Immun. 2023 Oct 17;91(10):e0043722. doi: 10.1128/iai.00437-22. Epub 2023 Sep 26. Infect Immun. 2023. PMID: 37750713 Free PMC article. Review.
-
Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.Ann Rheum Dis. 1991 Oct;50(10):677-9. doi: 10.1136/ard.50.10.677. Ann Rheum Dis. 1991. PMID: 1958088 Free PMC article.
-
Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone.Clin Exp Immunol. 1992 Nov;90(2):293-9. doi: 10.1111/j.1365-2249.1992.tb07945.x. Clin Exp Immunol. 1992. PMID: 1424289 Free PMC article.
-
Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform.Sensors (Basel). 2021 Jun 1;21(11):3829. doi: 10.3390/s21113829. Sensors (Basel). 2021. PMID: 34205852 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials